Liquid Biopsy Market
Liquid Biopsy Market - Global Industry Assessment & Forecast
#
Pages:
142
Base Year:
2022
Feb - 2023
Format:
Report Code:
VMR-2009
Segments Covered
By
Product & Services Assay Kits, Instruments, Services
-
By
Circulating Biomarkers Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Other Circulating Biomarkers
-
By
Applications Cancer Applications, Non-Cancer Applications
-
By
Cancer Applications Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancers
-
By
Non-Cancer Applications Non-Invasive Prenatal Testing (NIPT), Organ Transplantations, Infectious Disease Testing
-
By
Technology Multi-Gene Parallel Analysis using NGS, Single-Gene Analysis using PCR Microarrays
-
By
Clinical Applications Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring
-
By
End Users Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers, Other End Users
-
By
Sample Types Blood, Other Sample Types
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4.71 Billion |
 Revenue 2030:
|
USD 17.33 Billion |
 Revenue CAGR
(2023 - 2030): |
17.70% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Liquid Biopsy Market Segment Analysis
- Liquid Biopsy Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
- Assay Kits
- Instruments
- Services
- Liquid Biopsy Circulating Biomarkers Outlook (Revenue, USD Million, 2018 - 2030)
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Liquid Biopsy Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer Applications
- Non-Cancer Applications
- Liquid Biopsy Cancer Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Liquid Biopsy Non-Cancer Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Liquid Biopsy Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Liquid Biopsy Clinical Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Liquid Biopsy End Users Outlook (Revenue, USD Million, 2018 - 2030)
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Liquid Biopsy Sample Types Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Other Sample Types
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
North America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
North America Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
-
North America Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
-
North America Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
-
North America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
North America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
North America Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
North America Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- U.S.
- U.S. Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- U.S. Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- U.S. Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- U.S. Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- U.S. Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- U.S. Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- U.S. Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- U.S. Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U.S. Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- U.S. Liquid Biopsy Market, by Product & Services
- Canada
- Canada Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Canada Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Canada Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Canada Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Canada Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Canada Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Canada Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Canada Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Canada Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Canada Liquid Biopsy Market, by Product & Services
-
Mexico
- Mexico Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Mexico Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Mexico Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Mexico Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Mexico Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Mexico Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Mexico Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Mexico Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Mexico Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Mexico Liquid Biopsy Market, by Product & Services
-
North America Liquid Biopsy Market, by Product & Services
- Europe
-
Europe Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Europe Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Europe Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
-
Europe Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
-
Europe Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
-
Europe Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Europe Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Europe Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
Europe Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- U. K.
- U.K. Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- U.K. Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- U.K. Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- U.K. Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- U.K. Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- U.K. Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- U.K. Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- U.K. Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- U.K. Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- U.K. Liquid Biopsy Market, by Product & Services
- France
- France Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- France Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- France Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- France Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- France Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- France Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- France Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- France Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- France Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- France Liquid Biopsy Market, by Product & Services
-
Germany
- Germany Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Germany Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Germany Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Germany Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Germany Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Germany Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Germany Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Germany Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Germany Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Germany Liquid Biopsy Market, by Product & Services
-
Italy
- Italy Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Italy Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Italy Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Italy Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Italy Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Italy Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Italy Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Italy Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Italy Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Italy Liquid Biopsy Market, by Product & Services
-
Spain
- Spain Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Spain Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Spain Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Spain Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Spain Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Spain Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Spain Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Spain Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Spain Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Spain Liquid Biopsy Market, by Product & Services
-
Rest of Europe
- Rest of Europe Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Europe Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Europe Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Rest of Europe Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Rest of Europe Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Rest of Europe Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Europe Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Europe Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Europe Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Rest of Europe Liquid Biopsy Market, by Product & Services
-
Europe Liquid Biopsy Market, by Product & Services
- Asia Pacific
-
Asia Pacific Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Asia Pacific Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Asia Pacific Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
-
Asia Pacific Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
-
Asia Pacific Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
-
Asia Pacific Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Asia Pacific Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Asia Pacific Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
Asia Pacific Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- China
- China Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- China Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- China Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- China Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- China Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- China Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- China Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- China Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- China Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- China Liquid Biopsy Market, by Product & Services
- Japan
- Japan Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Japan Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Japan Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Japan Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Japan Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Japan Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Japan Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Japan Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Japan Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Japan Liquid Biopsy Market, by Product & Services
-
Germany
- Germany Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Germany Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Germany Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Germany Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Germany Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Germany Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Germany Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Germany Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Germany Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Germany Liquid Biopsy Market, by Product & Services
-
India
- India Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- India Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- India Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- India Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- India Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- India Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- India Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- India Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- India Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- India Liquid Biopsy Market, by Product & Services
-
South Korea
- South Korea Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South Korea Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South Korea Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- South Korea Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- South Korea Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- South Korea Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South Korea Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South Korea Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South Korea Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- South Korea Liquid Biopsy Market, by Product & Services
-
South East Asia
- South East Asia Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South East Asia Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South East Asia Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- South East Asia Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- South East Asia Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- South East Asia Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South East Asia Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South East Asia Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South East Asia Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- South East Asia Liquid Biopsy Market, by Product & Services
-
Rest of Asia Pacific
- Rest of Asia Pacific Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Asia Pacific Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Asia Pacific Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Rest of Asia Pacific Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Rest of Asia Pacific Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Rest of Asia Pacific Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Asia Pacific Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Asia Pacific Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Asia Pacific Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Rest of Asia Pacific Liquid Biopsy Market, by Product & Services
-
Asia Pacific Liquid Biopsy Market, by Product & Services
- Latin America
-
Latin America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Latin America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Latin America Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
-
Latin America Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
-
Latin America Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
-
Latin America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Latin America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Latin America Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
Latin America Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Brazil
- Brazil Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Brazil Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Brazil Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Brazil Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Brazil Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Brazil Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Brazil Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Brazil Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Brazil Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Brazil Liquid Biopsy Market, by Product & Services
- Argentina
- Argentina Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Argentina Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Argentina Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Argentina Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Argentina Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Argentina Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Argentina Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Argentina Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Argentina Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Argentina Liquid Biopsy Market, by Product & Services
-
Rest of Latin America
- Rest of Latin America Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Latin America Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Latin America Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Rest of Latin America Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Rest of Latin America Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Rest of Latin America Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Latin America Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Latin America Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Latin America Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Rest of Latin America Liquid Biopsy Market, by Product & Services
-
Latin America Liquid Biopsy Market, by Product & Services
- Middle East & Africa
-
Middle East & Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
-
Middle East & Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
-
Middle East & Africa Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
-
Middle East & Africa Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
-
Middle East & Africa Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
-
Middle East & Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
-
Middle East & Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
-
Middle East & Africa Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
-
Middle East & Africa Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- GCC Countries
- GCC Countries Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- GCC Countries Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- GCC Countries Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- GCC Countries Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- GCC Countries Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- GCC Countries Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- GCC Countries Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- GCC Countries Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- GCC Countries Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- GCC Countries Liquid Biopsy Market, by Product & Services
- South Africa
- South Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- South Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- South Africa Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- South Africa Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- South Africa Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- South Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- South Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- South Africa Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- South Africa Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- South Africa Liquid Biopsy Market, by Product & Services
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Liquid Biopsy Market, by Product & Services
- Assay Kits
- Instruments
- Services
- Rest of Middle East & Africa Liquid Biopsy Market, by Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Other Circulating Biomarkers
- Rest of Middle East & Africa Liquid Biopsy Market, by Applications
- Cancer Applications
- Non-Cancer Applications
- Rest of Middle East & Africa Liquid Biopsy Market, by Cancer Applications
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Other Cancers
- Rest of Middle East & Africa Liquid Biopsy Market, by Non-Cancer Applications
- Non-Invasive Prenatal Testing (NIPT)
- Organ Transplantations
- Infectious Disease Testing
- Rest of Middle East & Africa Liquid Biopsy Market, by Technology
- Multi-Gene Parallel Analysis using NGS
- Single-Gene Analysis using PCR Microarrays
- Rest of Middle East & Africa Liquid Biopsy Market, by Clinical Applications
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Rest of Middle East & Africa Liquid Biopsy Market, by End Users
- Reference Laboratories
- Hospitals & Physician Laboratories
- Academic & Research Centers
- Other End Users
- Rest of Middle East & Africa Liquid Biopsy Market, by Sample Types
- Blood
- Other Sample Types
- Rest of Middle East & Africa Liquid Biopsy Market, by Product & Services
-
Middle East & Africa Liquid Biopsy Market, by Product & Services
- North America
Vantage Market
Research | 13-Feb-2023
FAQ
Frequently Asked Question
What is the global demand for Liquid Biopsy in terms of revenue?
-
The global Liquid Biopsy valued at USD 4.71 Billion in 2022 and is expected to reach USD 17.33 Billion in 2030 growing at a CAGR of 17.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Bio-Rad Laboratories (U.S.), Biocept Inc. (U.S.), Guardant Health (U.S.), Illumina Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson (U.S.), Laboratory Corporation of America Holdings (U.S.), MDxHealth SA (Belgium), QIAGEN N.V. (Germany), Thermo Fisher Scientific Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 17.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Liquid Biopsy include
- Rising includence and prevalence of cancer
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Liquid Biopsy in 2022.
